4/16/2010 | CVPF | Combinatorx files $50 million shelf covering stock, debt, preferreds
|
10/11/2007 | PP | New Issue: CombinatoRx announces $35 million direct placement of stock
|
10/11/2007 | PP | Market Commentary: BB Holdings raises $50 million from notes, warrants; CombinatoRx to close $35 million direct offering
|
12/11/2006 | CV | Combinatorx files $75 million shelf registration
|
11/14/2006 | BT | CombinatoRx reports net loss for the third quarter of $8.4 million, quarterly revenue up
|
11/8/2006 | BT | CombinatoRx phase 2 clinical trial of CRx-102 in rheumatoid arthritis meets endpoints
|
6/30/2006 | BT | CombinatoRx amends agreements with Fovea, GE Capital Corp.
|
6/22/2006 | BT | CombinatoRx says CRx-102 improves pain in osteoarthritis study
|
6/12/2006 | BT | CombinatoRx says CRx-401 reduces mean fasting blood glucose levels by 39%
|
6/7/2006 | BT | CombinatoRx says CRx-150 fails to meet primary endpoint in phase 2 trial for periodontitis
|
6/1/2006 | BT | CombinatoRx, Cystic Fibrosis Foundation Therapeutics form drug development collaboration
|
5/22/2006 | BT | CombinatoRx reports second positive phase 2 study with CRx-102
|
5/11/2006 | BT | CombinatoRx revenue up, plans to use proceeds from $45.3 million stock offering for later-stage trials
|
4/21/2006 | BT | CombinatoRx receives $5.83 million infectious disease research grant
|
4/18/2006 | BT | CombinatoRx phase 2 trial shows CRx-170 increases breathing capacity in asthma patients
|
4/7/2006 | BT | CombinatoRx trial of CRx-119 in periodontitis fails to meet primary endpoint
|
4/3/2006 | BT | CombinatoRx data shows potential therapeutic treatment for brain cancer
|
3/27/2006 | BTPP | CombinatoRx CFO says $47.97 million PIPE will finance phase 2 trials
|
3/23/2006 | BT | Market Commentary: BioMarin, King deals on deck; Cephalon poised to slide Friday; CombinatoRx off on PIPE deal
|
3/23/2006 | PP | Market Commentary: Plains All American wraps $100 million PIPE for acquisition; Revlon raises $65.52 million
|
3/23/2006 | BTPP | New Issue: CombinatoRx prepares to close $47.97 million stock sale
|
2/22/2006 | BT | CombinatoRx discontinues CRx-140 as an oral product candidate for psoriasis
|
1/31/2006 | BT | CombinatoRx, Fovea Pharma agree to collaborate on developing ophthalmic drugs
|
1/30/2006 | BT | CombinatoRx reports CRx-102 leads to lower pain in patients with osteoarthritis of the hand
|
1/19/2006 | BT | CombinatoRx creates Singapore unit with Bio*One Capital of Singapore
|
11/18/2005 | BT | CombinatoRx underwriters exercise greenshoe for 900,000 shares, raising sale to $48.3 million
|
11/9/2005 | BT | New Issue: CombinatoRx raises $42 million in IPO at $7 per share - low end of sweetened talk of $7-$9
|
11/9/2005 | BT | Market Commentary: CombinatoRx surges on debut; Angiotech off; Fisher issues soar; Digene slips on stock sale plans
|
7/20/2005 | BT | CombinatoRx inks $23 million licensing pact with HenKan of Taiwan; IPO still in works
|